Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $33.2500 (-6.21%) ($32.4500 - $36.1000) on Wed. Jan. 24, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.62% (three month average) | RSI | 81 | Latest Price | $33.2500(-6.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 3.3% a day on average for past five trading days. | Weekly Trend | ATRA advances 29.5% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(51%) IBB(51%) IWO(50%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -2.81% in a week (0% probabilities). VIXM(-15%) TLT(-14%) UUP(-11%) UNG(-4%) VXX(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.81% (StdDev 5.62%) | Hourly BBV | 0 () | Intraday Trend | -5.8% | | | |
|
5 Day Moving Average | $31.81(4.53%) | 10 Day Moving Average | $28.86(15.21%) | 20 Day Moving Average | $23.47(41.67%) | To recent high | -6.2% | To recent low | 151.9% | Market Cap | $2.471b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |